Centre for Research at the CHUS

Centre for Research at the CHUS

Medical imaging benefiting preclinical and clinical studies

Centre de recherche du CHUS
Dr. André Carpentier - Director of the Diabetes, Obesity and Cardiovascular Complications at Research Axis Centre for Research at the CHUS (CRCHUS) – Université de Sherbrooke

Dr. André Carpentier
Director of the Diabetes, Obesity and Cardiovascular Complications Research Axis
Centre for Research at the CHUS (CRCHUS) – Université de Sherbrooke

A world leader in medical imaging, the Centre for Research at the CHUS (CRCHUS) conducts its early-stage clinical research activities at two CIUSSS sites in the Estrie region – the CHUS Hôpital Fleurimont and the Sherbrooke Hôtel-Dieu. Serving a population of more than 500,000 people in the Estrie region of Quebec, the CRCHUS stands out for the synergy that exists among its teams in basic, clinical, epidemiological and evaluative research.

More specifically, over the years, the CRCHUS has built an early-stage medical imaging clinical research infrastructure worthy of the talented experts who work there. The CRCHUS’s Sherbrooke Molecular Imaging Centre (CIMS), an imaging centre of excellence among the most highly developed in the world, has recognized expertise in the development of technologies and radiotracers, as well as in positron emission tomography (PET), magnetic resonance (MRI) and computed tomography (CT) imaging.

Areas of expertise

Cancer, diabetes, cardiovascular disease, pain, medical imaging, mother/child health and population health.

Design and operation of new preclinical tracers and biomedical instruments.

Consult the experts at our many analysis and medical imaging facilities and at our Clinical and Epidemiological Research Unit.


  • Preclinical studies and phase I to IV clinical studies
  • Experimental design of clinical studies and ethical oversight
  • Evaluation of radiotracers and radiopharmaceuticals with two cyclotrons and a full range of radiochemistry services
  • Cancer detection, staging and therapeutic monitoring
  • Metabolic studies: diabetes and cancer
  • Clinical pharmacokinetic modelling
  • Dosimetry assessment


  • Two cyclotrons, including a TR-24, to produce positron emission tomography (PET) tracers
  • Pediatric research area, two polysomnography rooms, a gymnasium, a physical exertion laboratory, observation and meeting rooms, a pharmacy and a laboratory for the processing and shipping of biological specimens.

Centre for Research at the CHUS video: https://www.youtube.com/watch?v=pdGTJinroLE&t=1s

Investigators specializing in phase I clinical trials

Dr. André Carpentier – endocrinology, diabetes, lipid and lipoprotein metabolism

Louis Gendron, Ph.D. – pain, opioids, in vitro and in vivo pharmacology

Dr. Michel Pavic – hematology-oncology, palliative care, physical activity and cancer

Brigitte Guérin, Ph.D. – Scientific manager of radiochemistry at the CIMS – synthesis of tracers, small animal imaging, cancer imaging and pulmonary imaging

Dr. Éric Turcotte – Scientific manager of clinical research at the CIMS – positron emission tomography, molecular, metabolic and functional imaging


Annie Morin, Ph.D.
Department Head – Operations and Infrastructure Support
Centre de recherche du CHUS, CIUSSS de l’Estrie – CHUS
3001, 12e avenue Nord, bureau 2983-7, Sherbrooke (Québec) J1H 5N4
T: +1 819 346-1110 ext. #12891